MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2017 International Congress

    Degree, onset and longevity of benefit achieved with Deep Brain Stimulation (DBS) of the subthalamic nucleus (STN) as assessed by the UPDRS.

    D. Caputo, O. Mark, D. Schneider, R. DiPaola, S. Danish, E. Hargreaves (New Brunswick, NJ, USA)

    Objective:  To show the degree, onset and longevity of benefit achieved with STN DBS at our center. Background: At our center, we administer the UPDRS-III…
  • 2017 International Congress

    GammaKnife subthalamotomy for Parkinson’s disease

    t. witjas, r. carron, a. eusebio, j.p. azulay, j. regis (marseille, France)

    Objective: To assess the feasibility of GammaKnife subthalamotomy in Parkinson's disease Background: Chronic STN stimulation is an established treatment for complicated PD. Bilateral subthalamotomy may…
  • 2017 International Congress

    The Accreditation and Certification of the Movement Disorders Subspecialty

    S. O'Shea, L. Gutmann, L. Faulkner (New York, NY, USA)

    Objective: The purpose of our study was to assess the sentiments of Movement Disorders fellowship program directors regarding the accreditation and certification of their subspecialty.…
  • 2017 International Congress

    Neuroprotective Potency of Tetrahydroisoquinoline a Novel Ayurveda Molecule in Experimental Parkinson’s Disease

    R. Banerjee, D. Nthenge-Ngumbau, R. Singh, P. Jaisankar, K. Mohanakumar, S. Biswas (Kolkata, India)

    Objective: Tetrahydroisoquinoline (TIQ) an identified alkaloid from ancient Indian ‘Ayurveda’ medicine for Parkinson’s disease (PD) was tested for neuroprotection in a cellular system and a…
  • 2017 International Congress

    Evaluation of Swallowing Function in Parkinson’s Disease Patients with and without Dysphagia Complaints

    E. Umay, E. Ozturk, I. Gundogdu, O. Delibas, A. Cakci, B. Gonenli, Y. Eren (Ankara, Turkey)

    Objective: To assess swallowing functions of symptomatic and asymptomatic patients Parkinson's disease (PD). Background: Swallowing studies in PD without dysphagia symptoms are lacking and swallowing…
  • 2017 International Congress

    WILSON’S DISEASE: A Mongolian case

    U. Dashdorj, S. Jambal (Ulaanbaatar 51, Mongolia)

    Objective: Objective: To determine the early clinical features that predict younger people who has Wilson’s disease(WD). Background: Backround: WD is fatal neurodegenerative  disorder that is…
  • 2017 International Congress

    Efficacy of Smartphone-enabled Active Tests in Automated PD Severity Assessment

    A. Zhan, S. Mohan, M. Elson, E. Dorsey, A. Terzis, S. Saria (Baltimore, MD, USA)

    Objective: To compare the efficacy of five smartphone-enabled active tests in detecting severity changes after medication, via an automated Parkinson Disease Severity Score (PDSS). Background:…
  • 2017 International Congress

    Exercise Trends Reported in Parkinson’s Patients

    P. Raje, C. Branson, M.P. de Leon, M. Saint-Hilaire, A. Hohler, S. Ning (Boston, MA, USA)

    Objective: To examine trends in type, frequency, and effectiveness of exercise in Parkinson’s patients based on gender, race, and years since diagnosis. Background: Exercise has…
  • 2017 International Congress

    FDG PET studies in the differential diagnose of atypical parkinsonism and dementia syndromes.

    M.C. Peralta, M. Tourreilles, D. Menna, P. Perez Leguizamon, F. Taragano, M. Bastianello (Buenos Aires, Argentina)

    Objective: To describe the fluorodeoxyglucose (FDG) metabolic pattern and clinical features in patients with clinical diagnose of atypical parkinsonism such as Progressive Supranuclear Palsy (PSP),…
  • 2017 International Congress

    The association between motor laterality and cognitive impairment in Parkinson’s disease

    J.S. Kim, J.W. Cho, J. Youn (Seoul, Republic of Korea)

    Objective: Our study aimed to compare the cognitive function depending on the one-sided symptom dominance for investigating association between specific cognitive function and asymmetric motor…
  • « Previous Page
  • 1
  • …
  • 288
  • 289
  • 290
  • 291
  • 292
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • #24475 (not found)
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Welcome to the MDS Abstracts Site
  • Effect of marijuana on Essential Tremor: A case report
  • Advanced Search
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley